DINGDANG HEALTH (09886) spent HKD 181,900 to repurchase 172,000 shares on April 16th.

13:54 17/04/2026

Dingdang Health (09886) announced that on April 16, 2026, the company repurchased 172,000 shares at a cost of 181,900 Hong Kong dollars, with a repurchase price of 1.05-1.06 Hong Kong dollars per share.

DINGDANG HEALTH (09886) announced that on April 16, 2026, the company spent 181.9 thousand Hong Kong dollars to repurchase 172 thousand shares, at a repurchase price of 1.05-1.06 Hong Kong dollars per share.

HK Stock Market Move | HANXBIO-B(03378) rose nearly 9% in the closing session. The company will present four poster research findings at the AACR annual conference.

Boji Pharmaceutical (02659) restructured the IND application of Ustekinumab (BJ044) and received acceptance, opening a new era of recombinant protein drugs.

New Stock News | Topu Numerical Control's Hong Kong IPO and domestic unlisted shares "fully circulating" have been registered with the China Securities Regulatory Commission.

HK Stock Market Move | HANXBIO-B(03378) rose nearly 9% in the closing session. The company will present four poster research findings at the AACR annual conference.

Boji Pharmaceutical (02659) restructured the IND application of Ustekinumab (BJ044) and received acceptance, opening a new era of recombinant protein drugs.

New Stock News | Topu Numerical Control's Hong Kong IPO and domestic unlisted shares "fully circulating" have been registered with the China Securities Regulatory Commission.